首页> 外文期刊>The Internet Journal of Rheumatology >Assessment of disease activity in Rheumatoid Arthritis using urinary CTx-I levels as a marker of bone destruction and serum IL-6 as a marker of inflammation.
【24h】

Assessment of disease activity in Rheumatoid Arthritis using urinary CTx-I levels as a marker of bone destruction and serum IL-6 as a marker of inflammation.

机译:使用尿CTx-1水平作为骨破坏的指标,血清IL-6作为炎症的指标,评估类风湿性关节炎的疾病活动性。

获取原文
       

摘要

Background and Objectives: Urinary C-terminal cross linking telopeptide of type 1 collagen (CTX-I) is a specific marker of bone resorption.Also, IL-6 in the synovial cavity may contribute to that in the serum and may raise its levels. The aim of this study was to measure urinary CTx-I and serum interleukin-6(IL-6) levels in rheumatoid arthritis (RA) patients and to use these markers to assess the disease activity by comparing them with the existing markers of disease activity. Methods: 35 RA patients, 18 patients suffering from osteoarthritis (OA) with / without inflammatory synovitis and 18 age - matched healthy controls were included in the study. Urinary CTx-I and serum IL-6 levels were measured in all of them.Results: A total of 71 subjects were included in the study. A positive correlation was found between CTx-I and age (p = 0.044, r = 0.362), DAS28 (p = 0.007, r = 0.451), swollen joint count (p = 0.006, r = 0.452) and tender joint count (p = 0.006, r = 0.453).Levels did not correlate with erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), Rheumatoid factor and disease duration. IL-6 levels were found to have significant associations with age (p = 0.012, r = 0.42), CRP (p = 0.048, r = 0.337), DAS28 (p = 0.024, r = 0.382), swollen joint count (p = 0.001, r = 0.555) and tender joint count (p = 0.04, r = 0.349). No correlations were found between IL-6 and ESR, Rheumatoid factor and disease duration. A positive correlation was also seen between CTx-I and IL-6 (p = 0.03, r = 0.352).Conclusions: Serum IL-6 and urinary CTx-I levels are markedly elevated in RA with active disease and their increased levels correlate with the existing markers of increased disease activity. Introduction Rheumatoid Arthritis (RA) is a chronic multisystem disease of unknown etiology. It is characterized by persistent inflammatory synovitis, usually involving multiple joints in a symmetrical distribution. The potential of the synovial inflammation to cause cartilage and bone erosions and subsequent changes in joint integrity is the hallmark of the disease.1 The overall prevalence of RA is around 1 % in the general population.2 India harbors around 5.4 % of the global burden of RA.3 Osteoclastic activation has been suggested to be the dominant process leading to bone resorption in Rheumatoid arthritis (RA). Most biochemical indices of bone resorption are related to collagen breakdown products such as hydroxyproline or the various collagen cross links and telopeptides.4 Of these , urinary C-terminal cross linking telopeptide of type 1 collagen(CTX-I) is a more specific marker of bone derived type 1 collagen fragments in urine in RA.5 Cross linking compounds pyridinoline( PYD) and deoxypyridinoline (DPD) levels in urine have previously been studied to assess collagen degradation6 and disease activity in RA. But CTX- I levels in urine have not been adequately studied. The appearance of pro-inflammatory cytokines in joint tissue/synovial fluid and serum/plasma of patients with arthritic conditions, suggest that they play a pivotal role in the local and systemic inflammatory response. However in many cases it has not been possible to relate known in vitro effects of pro-inflammatory cytokines to clinical and laboratory observations. IL-6 mediates the synthesis of acute phase proteins.7 Many attempts at establishing a correlation between this cytokine and the disease activity in RA have been made but the results obtained were inconsistent. However a recent animal trial on mice with antigen-induced arthritis confirms the important role of IL-6 in the development of disease.8 Also the synovial fluid in rheumatoid arthritis contains substantially increased amounts of IL-6.9 Using cytokine probes, it has been claimed that IL-6 in rheumatic synovial fluid originates from type B synovial lining cells and fibroblasts.1011 This IL-6 in the synovial cavity may contribute to that in the serum and may raise its levels. Thus the present study was conducted
机译:背景与目的:1型胶原的尿C末端交联端肽(CTX-1)是骨吸收的特异性标志物。滑膜腔中的IL-6可能也有助于血清中的IL-6并可能升高其水平。这项研究的目的是测量类风湿关节炎(RA)患者的尿液CTx-1和血清白细胞介素6(IL-6)水平,并通过将这些标记物与疾病活动性现有标记物进行比较,使用这些标记物来评估疾病活动性。方法:35名RA患者,18名患有/不患有炎性滑膜炎的骨关节炎(OA)患者和18名年龄匹配的健康对照者被纳入研究。测定所有患者的尿CTx-1和血清IL-6水平。结果:总共71名受试者被纳入研究。发现CTx-1与年龄(p = 0.044,r = 0.362),DAS28(p = 0.007,r = 0.451),关节肿胀(p = 0.006,r = 0.452)和嫩关节计数(p之间呈正相关。 = 0.006,r = 0.453)。水平与红细胞沉降率(ESR),C反应蛋白(CRP),类风湿因子和疾病持续时间无关。发现IL-6水平与年龄(p = 0.012,r = 0.42),CRP(p = 0.048,r = 0.337),DAS28(p = 0.024,r = 0.382),关节肿胀(p = 0.001,r = 0.555)和嫩关节计数(p = 0.04,r = 0.349)。 IL-6和ESR,类风湿因子与疾病持续时间之间没有相关性。结论:活动性疾病的RA患者血清IL-6和尿CTx-1水平显着升高,且与血浆中IL-6水平呈正相关(p = 0.03,r = 0.352)。疾病活动增加的现有标志。简介类风湿关节炎(RA)是一种病因不明的慢性多系统疾病。它的特征是持续性炎性滑膜炎,通常涉及对称分布的多个关节。滑膜发炎可能导致软骨和骨糜烂以及关节完整性随后发生变化,这是该疾病的标志。1RA的总患病率约为总人口的1%。2印度占全球负担的5.4%左右。 3破骨细胞活化被认为是导致类风湿关节炎(RA)骨吸收的主要过程。骨吸收的大多数生化指标与胶原分解产物有关,例如羟脯氨酸或各种胶原交联键和端肽。4其中,1型胶原的尿C端交联端肽(CTX-1)是一种更特异性的标志物。 RA中尿液中的骨衍生1型胶原蛋白片段。5尿液中的交联化合物吡啶吡啶(PYD)和脱氧吡啶啉(DPD)含量以前已被研究过,以评估RA中的胶原蛋白降解和疾病活性。但是尚未充分研究尿液中的CTX-I水平。关节炎患者的关节组织/滑液和血清/血浆中促炎细胞因子的出现,表明它们在局部和全身性炎症反应中起关键作用。然而,在许多情况下,不可能将促炎细胞因子的已知体外作用与临床和实验室观察联系起来。 IL-6介导急性期蛋白的合成[7]。尽管已经进行了许多尝试来建立这种细胞因子与RA中疾病活性之间的相关性,但是获得的结果并不一致。但是,最近一项针对抗原诱发性关节炎的小鼠的动物实验证实了IL-6在疾病发展中的重要作用。8此外,类风湿性关节炎中的滑液中IL-6.9的含量大大增加。认为风湿性滑液中的IL-6来源于B型滑膜衬里细胞和成纤维细胞。1011滑膜腔中的IL-6可能与血清中的IL-6有关系,并可能升高其水平。因此进行了本研究

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号